New clinical trial offers hope to diabetics!
Ninemsn - Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.
The trial will use insulin administered with a nasal spray to children and young adults who are genetically predisposed to developing Type 1 diabetes.
If successful, researchers believe it could offer thousands of children protection from the disease, and the opportunity to avoid a life of constant blood-sugar monitoring, insulin injections and a regimented diet.
Researchers from the University of Melbourne's Diabetes Vaccine Development Centre are seeking 13,000 people aged between four and 30 who have a blood relative with Type 1 diabetes - and a higher risk of developing the disease - to undergo screening for the trial.
From those, it is expected about two per cent will be eligible to take part in the trial.
Read more…
The trial will use insulin administered with a nasal spray to children and young adults who are genetically predisposed to developing Type 1 diabetes.
If successful, researchers believe it could offer thousands of children protection from the disease, and the opportunity to avoid a life of constant blood-sugar monitoring, insulin injections and a regimented diet.
Researchers from the University of Melbourne's Diabetes Vaccine Development Centre are seeking 13,000 people aged between four and 30 who have a blood relative with Type 1 diabetes - and a higher risk of developing the disease - to undergo screening for the trial.
From those, it is expected about two per cent will be eligible to take part in the trial.
Read more…
0 Comments:
Post a Comment
<< Home